293 related articles for article (PubMed ID: 32394947)
1. Should mast cells be considered therapeutic targets in multiple sclerosis?
Pinke KH; Zorzella-Pezavento SFG; Lara VS; Sartori A
Neural Regen Res; 2020 Nov; 15(11):1995-2007. PubMed ID: 32394947
[TBL] [Abstract][Full Text] [Related]
2. Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
Pinke KH; Zorzella-Pezavento SFG; de Campos Fraga-Silva TF; Mimura LAN; de Oliveira LRC; Ishikawa LLW; Fernandes AAH; Lara VS; Sartori A
Neurotherapeutics; 2020 Jan; 17(1):218-234. PubMed ID: 31463682
[TBL] [Abstract][Full Text] [Related]
3. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
Elieh-Ali-Komi D; Cao Y
Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.
Ravanidis S; Poulatsidou KN; Lagoudaki R; Touloumi O; Polyzoidou E; Lourbopoulos A; Nousiopoulou E; Theotokis P; Kesidou E; Tsalikakis D; Karacostas D; Grigoriou M; Chlichlia K; Grigoriadis N
Stem Cells Transl Med; 2015 Dec; 4(12):1450-62. PubMed ID: 26511651
[TBL] [Abstract][Full Text] [Related]
5. Important role of mast cells in multiple sclerosis.
Conti P; Kempuraj D
Mult Scler Relat Disord; 2016 Jan; 5():77-80. PubMed ID: 26856948
[TBL] [Abstract][Full Text] [Related]
6. Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Al-Izki S; Pryce G; Hankey DJ; Lidster K; von Kutzleben SM; Browne L; Clutterbuck L; Posada C; Edith Chan AW; Amor S; Perkins V; Gerritsen WH; Ummenthum K; Peferoen-Baert R; van der Valk P; Montoya A; Joel SP; Garthwaite J; Giovannoni G; Selwood DL; Baker D
Brain; 2014 Jan; 137(Pt 1):92-108. PubMed ID: 24287115
[TBL] [Abstract][Full Text] [Related]
7. Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
Costanza M; Colombo MP; Pedotti R
Int J Mol Sci; 2012 Nov; 13(11):15107-25. PubMed ID: 23203114
[TBL] [Abstract][Full Text] [Related]
8. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
9. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
Theoharides TC; Kempuraj D; Kourelis T; Manola A
Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as disease progression biomarkers and therapeutic targets in experimental autoimmune encephalomyelitis model of multiple sclerosis.
Martinez B; Peplow PV
Neural Regen Res; 2020 Oct; 15(10):1831-1837. PubMed ID: 32246624
[TBL] [Abstract][Full Text] [Related]
11. Mast cells: new targets for multiple sclerosis therapy?
Zappulla JP; Arock M; Mars LT; Liblau RS
J Neuroimmunol; 2002 Oct; 131(1-2):5-20. PubMed ID: 12458032
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Reichardt HM; Gold R; Lühder F
Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
[TBL] [Abstract][Full Text] [Related]
13. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
14. Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
Shalaby SM; Sabbah NA; Saber T; Abdel Hamid RA
IUBMB Life; 2016 Feb; 68(2):106-15. PubMed ID: 26757144
[TBL] [Abstract][Full Text] [Related]
15. Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.
Orian JM; D'Souza CS; Kocovski P; Krippner G; Hale MW; Wang X; Peter K
Front Immunol; 2021; 12():620963. PubMed ID: 33679764
[TBL] [Abstract][Full Text] [Related]
16. Mast Cells and Innate Lymphoid Cells: Underappreciated Players in CNS Autoimmune Demyelinating Disease.
Brown MA; Weinberg RB
Front Immunol; 2018; 9():514. PubMed ID: 29619025
[TBL] [Abstract][Full Text] [Related]
17. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis.
Secor VH; Secor WE; Gutekunst CA; Brown MA
J Exp Med; 2000 Mar; 191(5):813-22. PubMed ID: 10704463
[TBL] [Abstract][Full Text] [Related]
18. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune disease in the brain--how to spot the culprits and how to keep them in check.
Flügel A; Schläger C; Lühder F; Odoardi F
J Neurol Sci; 2011 Dec; 311 Suppl 1():S3-11. PubMed ID: 22206764
[TBL] [Abstract][Full Text] [Related]
20. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
